Nanolive has released it’s next generation immunotherapy solution: the LIVE T Cell Assay. This real-time digital assay combines label-free live cell imaging and AI-powered analysis to deliver continuous, multiparametric data – ranging from T cell activation to target cell interactions and killing.
Watch the product release, where we showcase the versatility of the LIVE T Cell Assay through case studies featuring CAR-T and bispecific antibody screening, highlighting the assay’s ability to characterize immunotherapeutic specificity, robustness, and efficacy, as well as its value across different stages of preclinical research and development.
Read our latest news
Simplifying drug delivery assessment: Industry perspectives
Optimization of drug delivery systems can become slow, resource intensive, and reliant on incomplete information. With one assay, Nanolive monitors the complete dynamics of drug delivery, reducing phototoxicity from labels and helping teams identify where delivery succeeds or fails.
Webinar – Investigating nanoparticle delivery with label-free live cell imaging
Watch our latest webinar, where Elizabeth Nelson shares research performed at the MIT Koch Institute for Integrative Cancer Research, demonstrating a live-cell imaging workflow to quantify the dynamic uptake of nanoparticles…
Move beyond endpoints with dynamic EC50
Discover case study data for a dynamic approach to monitoring EC50 to gain more accurate insights into drug function.